These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27935544)

  • 1. Identification of early-stage lung adenocarcinoma prognostic signatures based on statistical modeling.
    Wu C; Zhang D
    Cancer Biomark; 2017; 18(2):117-123. PubMed ID: 27935544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.
    Wan YW; Beer DG; Guo NL
    Lung Cancer; 2012 Apr; 76(1):98-105. PubMed ID: 22047960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma.
    Chang YH; Chen CM; Chen HY; Yang PC
    Sci Rep; 2015 Jun; 5():10979. PubMed ID: 26042604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
    Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
    Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression signature predicts recurrence in lung adenocarcinoma.
    Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
    Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.
    Rakha E; Pajares MJ; Ilie M; Pio R; Echeveste J; Hughes E; Soomro I; Long E; Idoate MA; Wagner S; Lanchbury JS; Baldwin DR; Hofman P; Montuenga LM
    Eur J Cancer; 2015 Sep; 51(14):1897-903. PubMed ID: 26235745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
    Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
    Guo NL; Wan YW
    Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-expression profiles predict survival of patients with lung adenocarcinoma.
    Beer DG; Kardia SL; Huang CC; Giordano TJ; Levin AM; Misek DE; Lin L; Chen G; Gharib TG; Thomas DG; Lizyness ML; Kuick R; Hayasaka S; Taylor JM; Iannettoni MD; Orringer MB; Hanash S
    Nat Med; 2002 Aug; 8(8):816-24. PubMed ID: 12118244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
    Sun Z; Wigle DA; Yang P
    J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma.
    Lv D; Yang H; Wang W; Xie Y; Hu W; Ye M; Chen X
    BMC Cancer; 2015 Oct; 15():687. PubMed ID: 26463718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.
    Yao J; Zhao Q; Yuan Y; Zhang L; Liu X; Yung WK; Weinstein JN
    PLoS One; 2012; 7(9):e45894. PubMed ID: 23029298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.
    Ringnér M; Staaf J
    Oncotarget; 2016 Aug; 7(33):52957-52973. PubMed ID: 27437773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized identification of disease-associated pathways with disrupted coordination of gene expression.
    Wang H; Cai H; Ao L; Yan H; Zhao W; Qi L; Gu Y; Guo Z
    Brief Bioinform; 2016 Jan; 17(1):78-87. PubMed ID: 26023086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.